Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development

Published on :

Developing new orphan therapies, increasing access to existing life-saving treatments, and lowering costs is a moral imperative. However, major challenges remain for the rare disease community to achieve these goals.

Summer internship program in precision medicine creates a win-win for students and local company

Published on :

Summer Internship Program in Precision Medicine Creates a Win-Win for Students and Local Company Jeeva Informatics, George Mason University and United National Diversity Coalition of America collaborate on successful internship [….]